Rodger Novak
Overview
Rodger Novak received an average of $3M in total compensation, including $454K in salary, at CRISPR Therapeutics AG from 2015 to 2018.
Source: SEC filings on April 30, 2019 and April 18, 2017.
Related executives
We found eight more executives who work or worked at CRISPR Therapeutics AG.
Samarth Kulkarni
CRISPR Therapeutics AG
Chief Executive Officer
Brendan Smith
CRISPR Therapeutics AG
Chief Financial Officer
Tony Ho
CRISPR Therapeutics AG
Former EVP, Research and Development
Lawrence Klein
CRISPR Therapeutics AG
Chief Operating Officer
James Kasinger
CRISPR Therapeutics AG
General Counsel
Michael Tomsicek
CRISPR Therapeutics AG
Chief Financial Officer
Marc Becker
CRISPR Therapeutics AG
Chief Financial Officer
Kala Subramanian
CRISPR Therapeutics AG